AVB-500 - Phase 3 Clinical Trial

FDA Approval·
·
Added

About This Event

Phase 3 initiation of dosing announced April 26, 2021. Interim analysis due 1Q 2022.

Why This Event Matters

Regulatory milestones can be important for biotech and pharmaceutical names because decisions may affect timelines, labeling, and commercial prospects. Outcomes are uncertain until confirmed by the company or agency materials; this listing is informational. The date shown is March 31, 2022 (America/New_York).

Source summary: Phase 3 initiation of dosing announced April 26, 2021. Interim analysis due 1Q 2022.

This listing is associated with ARAV. Market participants may watch these names around the event window for volatility or news flow.

Event Details

Occurs

Q1 2022Verified

Related Tickers

Impact Likelihood

24%

Source

Created By

catacal

Frequently Asked Questions

What is AVB-500 - Phase 3 Clinical Trial?
It is a stock market catalyst entry on Catacal—an event or release investors and traders may monitor. Details are summarized from the cited source and may be updated over time.
When is AVB-500 - Phase 3 Clinical Trial?
The calendar shows Mar 31, 2022 (America/New_York). Verify the exact time and any changes using the source link when planning around the event.
Why does AVB-500 - Phase 3 Clinical Trial matter for investors?
Regulatory outcomes can change timelines and risk profiles for drug and device developers.
Which stocks or sectors could be affected?
Symbols linked to this listing include ARAV; other names in the same industry group may also move with related news.
How is this event categorized?
Catacal groups this entry under "FDA Approval" for navigation. Categories help you find comparable catalysts and build a week-by-week watchlist.

Track Market-Moving Events

Monitor earnings, economic releases, lockups, conferences, and other catalysts that impact stocks.

View Catalyst Calendar

Comprehensive Calendar

Track earnings, product launches, FDA approvals, economic events, and more.

Impact Ratings

Know which catalysts have the greatest potential to impact stock prices.

Never Miss an Event

Get alerts and reminders so you're always prepared for market-moving events.

View Catalyst Calendar

Track upcoming market events

Get started

Never miss a market-moving event

Track company catalysts, earnings, IPOs, macro releases, and more in one calendar.

See upcoming catalysts →